Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Pharming Group N.V. - Filing #1883078

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
14,987,000 USD
23,078,000 USD
Revenue
205,622,000 USD
198,871,000 USD
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
22,458,000 USD
37,842,000 USD
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
5,323,000 USD
21,305,000 USD
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
4,982,000 USD
27,947,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.